Khiron Life Sciences (KHRNF) Income Statement
Khiron Life Sciences Income Statement
Last quarter (Q3 2022), Khiron Life Sciences's total revenue was $3.38M, a decrease of 3.82% from the same quarter last year. In Q3, Khiron Life Sciences's net income was $-3.58M. See Khiron Life Sciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 22 | Mar 21 | Mar 20 | Mar 19 | May 17 |
|---|---|---|---|---|---|
| $ 12.79M | $ 8.02M | $ 9.58M | $ 891.68K | $ 0.00 | |
| $ 6.37M | $ 7.01M | $ 2.44M | $ 297.36K | $ 0.00 | |
| $ 26.16M | $ 30.61M | $ 40.02M | $ 20.19M | $ 0.00 | |
| Depreciation and Amortization | $ 1.11M | $ 1.17M | $ 938.53K | $ 337.92K | $ 467.00 |
| $ -32.03M | $ -22.32M | $ -36.49M | $ -18.29M | $ -4.52M | |
| $ -19.79M | $ -23.60M | $ -37.43M | $ -19.90M | $ 0.00 | |
| $ -13.81M | $ -345.01K | $ 1.08M | $ -1.10M | $ 0.00 | |
| $ -33.59M | $ -23.95M | $ -36.36M | $ -19.73M | $ 0.00 | |
| $ -33.13M | $ -24.04M | $ -36.38M | $ -19.81M | $ 0.00 | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.20 | $ -0.20 | $ -0.36 | $ -0.41 | $ -0.16 |
| Diluted EPS | $ -0.20 | $ -0.20 | $ -0.36 | $ -0.41 | $ -0.16 |
| Weighted Average Shares Outstanding | 164.52M | 120.29M | 101.97M | 48.31M | 27.76M |
| Weighted Average Shares Outstanding (Diluted) | 164.52M | 120.29M | 101.97M | 48.52M | 27.76M |
Currency in CAD